Effects of fluvastatin on the activation of p38 mitogen-activated protein kinase in glomerular mesangial cells under high concentration of glucose

Yaoxue Xuebao

Volumn 44, Issue 2, 2009, Pages 121-125

  Li hui, Wang ^a   Guang li, W U ^a   Li xia, Zhang ^a   Xu dong, Huang ^a   Sai, L I ^a  

^a BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

Author keywords

3 hydroxy 3 methylglutaryl coa reductase inhibitor; Camp response element binding protein 1; Fluvastatin; Mesangial cell; P38 mitogen activated protein kinase; Transform growth factor 1

Indexed keywords

BETA ACTIN; COLLAGEN TYPE 4; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FIBRONECTIN; FLUINDOSTATIN; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LAMININ; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1; DIAMINO ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDOLE DERIVATIVE; MONOUNSATURATED FATTY ACID;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IN VITRO STUDY; MESANGIUM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; GENETICS; MALE; MESANGIUM CELL; METABOLISM; PHOSPHORYLATION; WISTAR RAT;

AMINO ACIDS, DIAMINO; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE IV; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FATTY ACIDS, MONOUNSATURATED; FIBRONECTINS; GLUCOSE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; MALE; MESANGIAL CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, WISTAR; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 64549102127     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tsiani E, Lekas P, Fantus IG, et al. High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG-2 and platelet-derived growth factor [J]. Am J Physiol Endocrinol Metab, 2002, 282: E161-E169.
2. Ho C, Hsu YC, Tseng CC, et al. Simvastatin alleviates diabetes-induced VEGF-mediated nephropathy via the modulation of Ras signaling pathway [J]. Ren Fail, 2008, 30: 557-565.
3. Wang LH, Duan HJ, Shi YH, et al. Effects of lovastatin on renal function and expression of phosphorylating-p38 mitogen-activated protein kinase in early diabetic glomeruli [J], Chin Crit Care Med 2004, 16: 734-737.
4. Stenvinkel P, Rodríguez-Ayala E, Massy ZA, et al. Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients [J]. Clin J Am Soc Nephrol, 2006, 1:281-287.
5. Danesh FR, Sadeghi MM, Amro N, et al. 3-Hydroxy-3- methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase / p21 signaling pathway: implications for diabetic nephropathy [J]. Proc Natl Acad Sci, 2002, 99: 8301-8305.
6. Kolavennu V, Zeng L, Peng H, et al. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control [J]. Diabetes, 2008, 57: 714-723.
7. Fujita H, Omori S, Ishikura K, et al. ERK and p38 mediate high-glucose-induced hypertrophy and TGF-beta expression in renal tubular ells [J]. Am J Physiol Renal Physiol, 2004, 286: F120-F126.
8. Guha M, Xu ZG, Tung D, et al. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes [J]. FASEB J, 2007, 21: 3355-3368.
9. Fraser D, Brunskill N, Ito T, et al. Long-term exposure of proximal tubular epithelial cells to glucose induces transforming growth factor-beta 1 synthesis via an autocrine PDGF loop [J]. Am J Pathol, 2003, 163: 2565-2567.
10. Usui H, Shikata K, Matsuda M, et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats [J]. Nephrol Dial Transplant, 2003,18: 265-272.
11. Yu HY, Inoguchi T, Nakayama M, et al. Statin attenuates high glucose-induced and angiotensin II-induced MAP kinase activity through inhibition of NAD(P)H oxidase activity in cultured mesangial cells [J]. Med Chem, 2005, 1: 461-466.
12. Banes-Berceli AK, Shaw S, Ma Q et al. Effect of simvastatin on high glucose- and angiotensin Il-induced activation of the JAK/STAT pathway in mesangial cells [J]. Am J Physiol Renal Physiol, 2006, 291: F116-F121.